19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10391106
APP PUB NO 20180141971A1
SERIAL NO

15639702

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are 19-nor C3,3-disubstituted steroids of Formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SAGE THERAPEUTICS INC215 FIRST STREET CAMBRIDGE MA 02142

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beresis, Richard T Shanghai, CN 12 168
Harrison, Boyd L Princeton Junction, US 126 1642
Martinez, Botella Gabriel Wayland, US 132 1511
Robichaud, Albert J Cambridge, US 33 1778
Salituro, Francesco G Marlborough, US 216 2924

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 27, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 27, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00